Furthermore, AβO downregulates the expression of the ER Ca2+ sensor STIM2 in a compensatory manner, impairing the neuronal store‐operated Ca2+ entry pathway, which further contributes to abnormal intracellular Ca2+ signaling observed in AD models (Zhang et al., 2015). The gene discussed is ABO; the disease is Alzheimer disease.